Matches in SemOpenAlex for { <https://semopenalex.org/work/W2057002810> ?p ?o ?g. }
- W2057002810 endingPage "194" @default.
- W2057002810 startingPage "183" @default.
- W2057002810 abstract "Background The goal of this work was the development of a gene targeting technology that will enable the delivery of therapeutic genes to brain cancer cells in vivo following intravenous administration. High-grade brain gliomas overexpress the epidermal growth factor receptor (EGFR) and EGFR antisense gene therapy could reduce the growth of EGFR-dependent gliomas. Methods A human EGFR antisense gene driven by the SV40 promoter in a non-viral plasmid carrying elements that facilitate extra-chromosomal replication was packaged in the interior of 85 nm pegylated immunoliposomes (PILs). The PILs were targeted to U87 human glioma cells with the 83-14 murine monoclonal antibody (MAb) to the human insulin receptor (HIR). Results Confocal fluorescent microscopy demonstrated that the unconjugated HIR MAb is rapidly internalized by the glioma cells. Endocytosis followed by entry into the nucleus was also demonstrated for the HIR MAb conjugated PILs carrying fluorescein-labeled plasmid DNA. The PILs delivered exogenous genes to virtually all cells in culture, based on β-galactosidase histochemistry. The targeting of a luciferase gene to the U87 cells with the PILs resulted in luciferase levels in excess of 150 pg/mg protein after 72 h of incubation. The level of luciferase gene expression in the U87 cells achieved with the PIL gene targeting system was comparable to that with lipofectamine. Targeting the EGFR antisense gene to U87 glioma cells with the PILs resulted in more than 70% reduction in [3H]thymidine incorporation into the cells; this was paralleled by a 79% reduction in the level of immunoreactive EGFR. Conclusion The present work describes the targeting of an EGFR antisense gene to human brain cancer cells, which results in a 70–80% inhibition in cancer cell growth. PILs provide a new approach to gene targeting that is effective in vivo following intravenous administration without viral vectors. Copyright © 2002 John Wiley & Sons, Ltd." @default.
- W2057002810 created "2016-06-24" @default.
- W2057002810 creator A5027480548 @default.
- W2057002810 creator A5052152398 @default.
- W2057002810 creator A5073892880 @default.
- W2057002810 creator A5075893557 @default.
- W2057002810 date "2002-01-01" @default.
- W2057002810 modified "2023-09-23" @default.
- W2057002810 title "Receptor-mediated delivery of an antisense gene to human brain cancer cells" @default.
- W2057002810 cites W1508288896 @default.
- W2057002810 cites W1516338367 @default.
- W2057002810 cites W1532008773 @default.
- W2057002810 cites W1553385403 @default.
- W2057002810 cites W1592685130 @default.
- W2057002810 cites W1973071934 @default.
- W2057002810 cites W1984512523 @default.
- W2057002810 cites W1985951814 @default.
- W2057002810 cites W1986129921 @default.
- W2057002810 cites W2002294272 @default.
- W2057002810 cites W2013878898 @default.
- W2057002810 cites W2021795851 @default.
- W2057002810 cites W2022261207 @default.
- W2057002810 cites W2034048441 @default.
- W2057002810 cites W2037799052 @default.
- W2057002810 cites W2053535808 @default.
- W2057002810 cites W2055810294 @default.
- W2057002810 cites W2057470417 @default.
- W2057002810 cites W2068566546 @default.
- W2057002810 cites W2074762435 @default.
- W2057002810 cites W2077121771 @default.
- W2057002810 cites W2113634953 @default.
- W2057002810 cites W2118878458 @default.
- W2057002810 cites W2140375000 @default.
- W2057002810 cites W214589945 @default.
- W2057002810 cites W2146820631 @default.
- W2057002810 cites W4247546166 @default.
- W2057002810 cites W98495447 @default.
- W2057002810 doi "https://doi.org/10.1002/jgm.255" @default.
- W2057002810 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/11933219" @default.
- W2057002810 hasPublicationYear "2002" @default.
- W2057002810 type Work @default.
- W2057002810 sameAs 2057002810 @default.
- W2057002810 citedByCount "119" @default.
- W2057002810 countsByYear W20570028102012 @default.
- W2057002810 countsByYear W20570028102013 @default.
- W2057002810 countsByYear W20570028102014 @default.
- W2057002810 countsByYear W20570028102015 @default.
- W2057002810 countsByYear W20570028102016 @default.
- W2057002810 countsByYear W20570028102017 @default.
- W2057002810 countsByYear W20570028102018 @default.
- W2057002810 countsByYear W20570028102019 @default.
- W2057002810 countsByYear W20570028102020 @default.
- W2057002810 countsByYear W20570028102021 @default.
- W2057002810 countsByYear W20570028102022 @default.
- W2057002810 countsByYear W20570028102023 @default.
- W2057002810 crossrefType "journal-article" @default.
- W2057002810 hasAuthorship W2057002810A5027480548 @default.
- W2057002810 hasAuthorship W2057002810A5052152398 @default.
- W2057002810 hasAuthorship W2057002810A5073892880 @default.
- W2057002810 hasAuthorship W2057002810A5075893557 @default.
- W2057002810 hasBestOaLocation W20570028101 @default.
- W2057002810 hasConcept C104317684 @default.
- W2057002810 hasConcept C111599444 @default.
- W2057002810 hasConcept C135983454 @default.
- W2057002810 hasConcept C153911025 @default.
- W2057002810 hasConcept C159654299 @default.
- W2057002810 hasConcept C185592680 @default.
- W2057002810 hasConcept C203014093 @default.
- W2057002810 hasConcept C2778227246 @default.
- W2057002810 hasConcept C40767141 @default.
- W2057002810 hasConcept C49923114 @default.
- W2057002810 hasConcept C502942594 @default.
- W2057002810 hasConcept C54009773 @default.
- W2057002810 hasConcept C542903549 @default.
- W2057002810 hasConcept C54355233 @default.
- W2057002810 hasConcept C55493867 @default.
- W2057002810 hasConcept C81885089 @default.
- W2057002810 hasConcept C86803240 @default.
- W2057002810 hasConcept C92087593 @default.
- W2057002810 hasConceptScore W2057002810C104317684 @default.
- W2057002810 hasConceptScore W2057002810C111599444 @default.
- W2057002810 hasConceptScore W2057002810C135983454 @default.
- W2057002810 hasConceptScore W2057002810C153911025 @default.
- W2057002810 hasConceptScore W2057002810C159654299 @default.
- W2057002810 hasConceptScore W2057002810C185592680 @default.
- W2057002810 hasConceptScore W2057002810C203014093 @default.
- W2057002810 hasConceptScore W2057002810C2778227246 @default.
- W2057002810 hasConceptScore W2057002810C40767141 @default.
- W2057002810 hasConceptScore W2057002810C49923114 @default.
- W2057002810 hasConceptScore W2057002810C502942594 @default.
- W2057002810 hasConceptScore W2057002810C54009773 @default.
- W2057002810 hasConceptScore W2057002810C542903549 @default.
- W2057002810 hasConceptScore W2057002810C54355233 @default.
- W2057002810 hasConceptScore W2057002810C55493867 @default.
- W2057002810 hasConceptScore W2057002810C81885089 @default.
- W2057002810 hasConceptScore W2057002810C86803240 @default.
- W2057002810 hasConceptScore W2057002810C92087593 @default.
- W2057002810 hasIssue "2" @default.